BILIRUBIN PROCEDURE, TEKPOINT TOT & DIR.— 510(k) K770458
Substantially EquivalentIcn Pharmaceuticals, Inc.
FDA 510(k) clearance K770458 for BILIRUBIN PROCEDURE, TEKPOINT TOT & DIR., Substantially Equivalent on 1977-05-10. Applicant: Icn Pharmaceuticals, Inc.. Device class: 2.
Clearance details
- Applicant
- Icn Pharmaceuticals, Inc.
- Product code
- Code CIG
- Device class
- Class 2
- Regulation
- 21 CFR 862.1110
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Orangeburg, NY, US
Recent devices under product code CIG
view allMore clearances from Icn Pharmaceuticals, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.